Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -13.22M
June 30, 2026 -1.665M
March 31, 2026 21.38M
December 31, 2025 9.458M
September 30, 2025 -3.178M
June 30, 2025 -18.21M
March 31, 2025 6.375M
December 31, 2024 28.42M
September 30, 2024 50.32M
June 30, 2024 70.76M
March 31, 2024 84.18M
December 31, 2023 -325.06M
Date Value
September 30, 2023 -307.18M
June 30, 2023 -292.52M
March 31, 2023
December 31, 2022 -252.32M
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021 -209.32M
September 30, 2021 -197.41M
June 30, 2021
March 31, 2021
December 31, 2020 -172.72M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Co-Diagnostics, Inc. 9.425M
Spectral AI, Inc. -15.43M
Omnicell, Inc. 1.317B
Oncolytics Biotech, Inc. -7.503M
Sangamo Therapeutics, Inc. -18.96M

Shareholders Equity (Quarterly) Related Metrics